Iovance Biotherapeutics (NASDAQ:IOVA) Reaches New 1-Year Low Following Analyst Downgrade
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA – Get Free Report) reached a new 52-week low during trading on Saturday after Baird R W downgraded the stock from a strong-buy rating to a hold rating. The stock traded as low as $1.65 and last traded at $1.75, with a volume of 112141445 shares trading hands. The stock had […]
